APA (7th ed.) Citation

L, S., C, B., JC, I., F, B., A, T., L, R., . . . D, L. P. (2022). JAK2 V617F polycythemia vera and essential thrombocythemia: Dynamic clinical features associated with long-term outcomes. Blood cancer journal, 12(4), 56. https://doi.org/10.1038/s41408-022-00646-0

Chicago Style (17th ed.) Citation

L, Sureau, et al. "JAK2 V617F Polycythemia Vera and Essential Thrombocythemia: Dynamic Clinical Features Associated with Long-term Outcomes." Blood Cancer Journal 12, no. 4 (2022): 56. https://doi.org/10.1038/s41408-022-00646-0.

MLA (9th ed.) Citation

L, Sureau, et al. "JAK2 V617F Polycythemia Vera and Essential Thrombocythemia: Dynamic Clinical Features Associated with Long-term Outcomes." Blood Cancer Journal, vol. 12, no. 4, 2022, p. 56, https://doi.org/10.1038/s41408-022-00646-0.